0001213900-22-009200.txt : 20220224 0001213900-22-009200.hdr.sgml : 20220224 20220224160140 ACCESSION NUMBER: 0001213900-22-009200 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220224 DATE AS OF CHANGE: 20220224 EFFECTIVENESS DATE: 20220224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: G Medical Innovations Holdings Ltd. CENTRAL INDEX KEY: 0001760764 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-434912 FILM NUMBER: 22670798 BUSINESS ADDRESS: STREET 1: 5 OPPENHEIMER ST. CITY: REHOVOT STATE: L3 ZIP: 7670105 BUSINESS PHONE: 972-89584777 MAIL ADDRESS: STREET 1: 5 OPPENHEIMER ST. CITY: REHOVOT STATE: L3 ZIP: 7670105 D 1 primary_doc.xml X0708 D LIVE 0001760764 G Medical Innovations Holdings Ltd. 5 OPPENHEIMER STREET REHOVOT L3 ISRAEL 7670105 972 544 33 8822 CAYMAN ISLANDS None None Corporation true Kenneth Melani 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Director Yacov Geva 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Executive Officer Director Kobi Ben-Efraim 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Executive Officer Benny Tal 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Executive Officer Oded Shahar 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Executive Officer Dror Nuriel-Roth 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Executive Officer Yehoshua Gleitman 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Director Brendan de Kauwe 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Director Zeev Rotstein 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Director Urs Wettstein 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Director Chanan Epstein 5 Oppenheimer Street Rehovot L3 ISRAEL 7670105 Director Other Health Care Decline to Disclose 06b false 2022-02-02 false true true true false 0 A.G.P./Alliance Global Partners 8361 None None 590 MADISON AVENUE 28TH FLOOR NEW YORK NY NEW YORK 10022 NY NEW YORK false 12100000 12100000 0 The securities were issued to two institutional investors in a private placement of an aggregate of: 1,620,000 ordinary shares, pre-funded warrants to purchase up to 800,000 ordinary shares, and warrants to purchase up to 2,420,000 ordinary shares. false 2 840000 0 A.G.P./Alliance Global Partners received an $840,000 cash placement fee and reimbursement of certain expenses. A.G.P./Alliance Global Partners received warrants to purchase up to 120,000 ordinary shares with an exercise price of $5.00. 0 Issuer expects to use proceeds from the offering for partial repayment of existing debt and working capital purposes. false G Medical Innovations Holdings Ltd. /s/ Kobi Ben-Efraim Kobi Ben-Efraim Chief Financial Officer 2022-02-24